Disclosure Panels Details Page
Myeloproliferative Neoplasms Panel - Disclosures as of 04/14/2020
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Mary Anne Bergman | None | None | None | None | - |
| Marian Birkeland PhD | None | None | None | None | - |
| Prithviraj Bose MD | Astellas Pharma US, Inc. Blueprint Medicines Celgene Corporation Constellation Pharmaceuticals CTI BioPharma Corp. Incyte Corporation Kartos Therapeutics NS Pharma Pfizer Inc. Promedior, Inc. |
None | Celgene Corporation CTI BioPharma Corp. Incyte Corporation Kartos Therapeutics |
None | ✔ |
| Mariana Castells MD, PhD | None | None | Baxalta Blueprint Medicines sanofi-aventis U.S. |
None | - |
| Michael Deininger MD, PhD | None | Adelphi Ascentage Pharma Blueprint Medicines Fusion Pharma Human Genome Sciences, Inc. Incyte Corporation Medscape Novartis Pharmaceuticals Corporation Pfizer Inc. Sangamo Takeda Pharmaceuticals North America, Inc. Tempus Labs, Inc TRM |
None | None | - |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Andrew Dunbar MD | None | None | None | None | ✔ |
| Aaron Gerds MD, MS | Celgene Corporation CTI BioPharma Corp. Genentech, Inc. Gilead Sciences, Inc. Imago Biosciences Incyte Corporation Roche Laboratories, Inc. Samus Theraputics |
Celgene Corporation | None | None | ✔ |
| Jason Gotlib MD, MS | Blueprint Medicines Celgene Corporation CTI BioPharma Corp. Deciphera Pharmaceuticals, Inc. Gilead Sciences, Inc. Incyte Corporation Kartos Pharmacyclics Promedior, Inc. Seattle Genetics, Inc. |
Blueprint Medicines Deciphera Pharmaceuticals, Inc. Gilead Incyte Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Krishna Gundabolu MBBS, MS, FACP | None | BioMarin Blueprint Medicines Jazz Pharmaceuticals Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | Stock in Geron|Stock in Portola Pharmaceuticals | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Laura Hanisch PsyD | None | None | None | None | - |
| Kyle Herrmann BSN, RN, OCN | None | None | None | None | - |
| Elizabeth Hexner MD, MS | Blueprint Medicines Novartis Pharmaceuticals Corporation |
None | None | None | ✔ |
| Gabriela Hobbs MD | None | Argos Therapeutics Bristol Myers Squibb Celgene Corporation Jazz Pharmaceuticals Inc. Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Cindy Hochstetler PhD | None | None | None | None | - |
| Tania Jain MBBS | None | Caredx Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Catriona Jamieson MD, PhD | Celgene Corporation | None | None | Forty Seven Inc. | - |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Andrew Kuykendall MD | AbbVie, Inc. Blueprint Medicines Celgene Corporation Forbius Incyte Corporation Protagonist Therapeutics |
AbbVie, Inc. Blueprint Medicines Incyte Corporation Prelude |
Celgene Corporation Incyte Corporation |
None | ✔ |
| Brandon McMahon MD | None | None | None | None | - |
| Sanjay Mohan MD, MSCI | Takeda Pharmaceuticals North America, Inc. | None | None | None | ✔ |
| Stephen Oh MD, PhD | None | Blueprint Medicines Celgene Corporation CTI BioPharma Corp. Disc Medicine Incyte Corporation Kartos |
None | None | ✔ |
| Animesh Pardanani PhD, MBBS | None | None | None | None | ✔ |
| Sharon Park PharmD, BCOP | None | None | None | None | - |
| Nikolai Podoltsev MD, PhD | AI Therapeutics Arog Pharmaceuticals Astellas Pharma US, Inc. Boehringer Ingelheim GmbH Celator Pharmaceuticals Celgene Corporation CTI BioPharma Corp. Daiichi- Sankyo Co. Genentech, Inc. Kartos Therapeutics Samus Therapeutics Sunesis Pharmaceuticals, Inc. |
Blueprint Medicines Bristol Myers Squibb Celgene Corporation CTI BioPharma Corp. Incyte Corporation Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Erik Ranheim MD, PhD | None | None | None | None | - |
| Leslie Ray PharmD | None | None | None | None | - |
| Lindsay Rein MD | Celgene Corporation CTI BioPharma Corp. |
Blueprint Medicines Celgene Corporation |
Novartis Pharmaceuticals Corporation | None | ✔ |
| Rachel Salit MD | None | None | Incyte Corporation Partner Therapeutics |
None | ✔ |
| David Snyder MD | None | None | None | None | ✔ |
| Brady Stein MD, MHS | Constellation Pharmaceuticas CTI BioPharma Corp. Takeda Pharmaceuticals North America, Inc. |
Apexx Oncology | None | None | ✔ |
| Hema Sundar PhD | None | None | None | None | - |
| Moshe Talpaz MD | Takeda Pharmaceuticals North America, Inc. | Celgene Corporation CTI BioPharma Corp. Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Swapna Thota MD | None | Blueprint Medicines | Incyte Corporation | None | ✔ |
| Pankit Vachhani MD | None | None | Agios, Inc. Astellas Pharma US, Inc. CTI BioPharma Corp. Incyte Corporation Jazz Pharmaceuticals Inc. |
None | ✔ |
| Martha Wadleigh MD | None | None | None | None | - |
| Katherine Walsh MD | None | None | None | None | ✔ |